Investigation of the efficacy and adverse effects of lacosamide over 36 months
Epilepsy & Behavior · 2023
DOI: 10.1016/j.yebeh.2023.109227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2023. Verfasst von Kei Wakabayashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Jichi Medical University, Division of Human Genetics, Center for Molecular Medicine, Jichi Medical University, Japan. Elect…. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Generalized. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the efficacy and retention rate of lacosamide (LCM) over 36 months as a treatment for children and adolescents with focal and generalized epilepsy based on a retrospective study. METHODS: All patients prescribed LCM as monotherapy and add-on therapy between October 2016 and September 2019 at Jichi Children's Medical Center Tochigi were included in the study. The response rate, retention rate, and adverse effects were calculated. RESULTS: A total of 126 (female, n = 73) patients of 1.3 to 34.9 years old (median age: 12.8 years; mean ± SD 13.2 ± 6.6 years) received LCM as monotherapy or add-on treatment for focal, generalized, and combined focal and generalized epilepsy. The response rate was 40.5% at 3 months, 40.5% at 6 months, 38.1% at 9 months, 35.7% at 12 months, 25.9% at 24 months, and 29.4% at 36 months. For 34 patients who were observable for 36 months, the retention rate was 70.6% at 3 months, but then gradually declined to 34.8% at 36 months. According to the number of concomitant anti-seizure medications (ASMs), the retention rate was higher in patients receiving
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Jichi Medical University, Division of Human Genetics, Center for Molecular Medicine, Jichi Medical University, Japan. Electronic address: r1245wk@jichi.ac.jp.
- Department of Pediatrics, Jichi Medical University, Division of Human Genetics, Center for Molecular Medicine, Jichi Medical University, Japan. Electronic address: hosaka@jichi.ac.jp.
- Department of Pediatrics, Jichi Medical University, Division of Human Genetics, Center for Molecular Medicine, Jichi Medical University, Japan.
Zitieren
APA
Wakabayashi, K., Osaka, H., Yamagishi, H., Kuwajima, M., Ikeda, T., Matsumoto, A., Muramatsu, K., & Yamagata, T. (2023). Investigation of the efficacy and adverse effects of lacosamide over 36 months. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2023.109227
Vancouver
Wakabayashi K, Osaka H, Yamagishi H, Kuwajima M, Ikeda T, Matsumoto A, et al. Investigation of the efficacy and adverse effects of lacosamide over 36 months. Epilepsy & Behavior. 2023. doi:10.1016/j.yebeh.2023.109227
BibTeX
@article{Wakabayashi2023,
author = {Wakabayashi, Kei and Osaka, Hitoshi and Yamagishi, Hirokazu and Kuwajima, Mari and Ikeda, Takahiro and Matsumoto, Ayumi and Muramatsu, Kazuhiro and Yamagata, Takanori},
title = {Investigation of the efficacy and adverse effects of lacosamide over 36 months},
journal = {Epilepsy & Behavior},
year = {2023},
doi = {10.1016/j.yebeh.2023.109227}
}
EUVIMED